Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Are There Differences in Return-to-Work Experiences for Workers Who Acquired COVID-19 at Work Compared to Workers who Sustained a Non-COVID-19 Work-Related Injury or Illness?

Created on 29 Jun 2026

Authors

Peter Smith, Colette Severin, Victoria Nadalin, Nancy Carnide, Arif Jetha, Mieke Koehoorn, Cheryl E Peters, Cameron Mustard

Published in

Journal of occupational rehabilitation. Jun 29, 2026. Epub Jun 29, 2026.

Abstract

To compare rates of return to work (RTW), at 18 months post-injury/infection, between workers with an absence from work due to COVID-19 and those with non-COVID injuries and illnesses, and to examine if RTW differences are explained by different factors in the RTW process.
Telephone interviews were conducted among 18,000 workers with accepted lost-time workers' compensation claims 18 months after their claim acceptance: 607 with work-related COVID-19 infections (oversampled) and 393 with other work-related injuries/illnesses. Potential outcome mediation models examined factors at the individual, workplace, healthcare provider, and system level involved in differences in RTW between workers with COVID-19 and non-COVID-19 claims, adjusting for a range of confounders.
At 18 months post-injury, approximately 13 more workers with COVID-19 infections were at work, per 100 workers, compared to those with other injuries or illnesses. Differences in self-rated health, experiencing financial difficulties, and disagreement with the workers' compensation agency, explained between 12 and 21% of these total differences (between 1 and 2 more workers returning to work per 100 workers). Other mediators explained relatively little of the total effect.
Workers with work-related COVID-19 infections have better RTW rates, 18 months post-injury, compared to workers with other types of work-related injuries. The results of our study suggest that factors identified as important for RTW at the workplace and healthcare provider level may not be generalizable to the context of COVID-19 infections, within the context of the COVID pandemic.

PMID:
42371267
Bibliographic data and abstract were imported from PubMed on 29 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement